Immunocore
UKEntry
2021
Hold
5yr
Status
Active
Who owns Immunocore?
Immunocore is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021. Across its history, Immunocore has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Rosetta CapitalRosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Rosetta CapitalActive
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries
General AtlanticActive
2021 · present(5yr) · General Atlantic Portfolio · Buyout
More from Rosetta Capital V
Other portfolio companies in the same fund.
Ireland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Immunocore
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Immunocore?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Immunocore.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue